NEOS Adds MLP & Energy Infrastructure Income ETF to Roster
Etftrends· 2025-12-19 20:01
"NEOS has had success gathering assets in 2025 by offering advisors options based high income strategies,†said TMX VettaFi Head of Research Todd Rosenbluth, noting the success of their other funds — namely the NEOS S&P 500 High Income ETF (SPYI) and NEOS Nasdaq 100 High Income ETF (QQQI). "It is great to see them continue to expand their lineup for the MLP investment style.†In an easing monetary policy environment, yields start to fall in line with rate cuts. Bond investors might be seeking to supplant th ...
Bitcoin ETF Landscape Shifts as U.S. Policy Changes
Etftrends· 2025-12-19 20:01
The policy changes include the establishment of a U.S. strategic bitcoin reserve and the GENIUS Act, signed in July 2025, which classified stablecoins as non-securities to support U.S. Treasury demand, according to the report. Trump Media & Technology Group (DJT) ranks among the top 10 corporate Bitcoin holders with 11,542 BTC. Bitcoin ETF investors are navigating a transformed policy environment in the United States, with the federal government designating the digital asset as a matter of national strategi ...
The Gap: Affordable Basics Are Winning The Day
Seeking Alpha· 2025-12-19 20:01
As we exit 2025, one of the key trends that has dominated headlines is the continued perception that life in the U.S. is becoming increasingly unaffordable. The fallout effects of this general consensus can be keenly feltWith combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to several seed-round startups, Gary Alexander has exposure to many of the themes shaping the industry today. He has been a regular contributor on Seekin ...
Nuclear's Comeback Trade: Why Tortoise Launched A Full-Stack Nuclear ETF
Benzinga· 2025-12-19 20:01
Tortoise Capital Advisors is doubling down on nuclear energy with the launch of the Tortoise Nuclear Renaissance ETF (NYSE:TNUK), an actively managed fund aimed at capturing what the firm sees as a durable, execution-driven shift in global power markets. • What’s going on with TNUK?The timing, according to Matt Sallee, executive vice president and head of investments at Tortoise Capital, is anything but coincidental. He points to a series of concrete policy and demand-side developments that have transformed ...
SEC Seeks 10-Year Ban for Ellison, 8 Years for Wang and Singh
Yahoo Finance· 2025-12-19 20:00
The Securities and Exchange Commission filed proposed final consent judgments today seeking officer-and-director bars against three former FTX executives who testified against Sam Bankman-Fried, with Caroline Ellison facing a decade-long prohibition, while Gary Wang and Nishad Singh would receive eight-year restrictions. The filings in Manhattan federal court formalize settlement terms for executives who cooperated extensively with prosecutors during Bankman-Fried’s criminal trial but still face permanen ...
Cannabis Is Running Into the Same Wall Plastics Already Hit, SMX Breaks Through it
Accessnewswire· 2025-12-19 20:00
NEW YORK, NY / ACCESS Newswire / December 19, 2025 / Cannabis did not design its infrastructure for permanence. It designed it for speed. ...
Graham: A.I. & Fed Top 2026 Themes, Top Picks in ANET, COHR & LLY
Youtube· 2025-12-19 20:00
of Andrew Graham, managing partner, Jackson Square Capital, is with me to talk about the market action as we sort of wrap up this year. How are you feeling about the market right now. >> Well, I I feel like we've gone through another, you know, pullback in the momentum factor.You see that in the tech tape up until, you know, yesterday's solid solid micron report. Um, and there's follow through today. Um, I think it's kind of chopped.I guess what I'll give you a ba hug. How about that. this time of the year. ...
Better Buy in 2026: Pfizer or Merck?
The Motley Fool· 2025-12-19 20:00
This year has been one to forget for these pharmaceutical giants.Pfizer (PFE +1.20%) and Merck (MRK +0.71%) are two pharmaceutical giants that have lagged broader equities this year. Both have delivered unimpressive financial results recently, and are facing a somewhat uncertain medium-term outlook as they seek ways to navigate upcoming patent cliffs.Both could make significant progress toward that goal in 2026, but which one is the better option for investors heading into the new year? Let's find out. The ...
Standard Uranium CEO discusses 2026 drill plans - ICYMI
Proactiveinvestors NA· 2025-12-19 19:58
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
INSP FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
Globenewswire· 2025-12-19 19:58
NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingenc ...